Jeffrey P. Hodge

Phase I Trial of Pazopanib in Patients with Advanced Cancer

Herbert I. Hurwitz, Afshin Dowlati, Shermini Saini et al. · Clinical Cancer Research · 2009 · 413 citations · Full text

Medicine, Oncology, Pharmacology +14

A Phase II, open-label study evaluating pazopanib in patients with recurrent ovarian cancer

Michael Friedländer, Kenneth C. Hancock, Danny Rischin et al. · Gynecologic Oncology · 2010 · 226 citations

Medicine, Oncology, Pharmacology +15

Phase I Study of 506U78 Administered on a Consecutive 5-Day Schedule in Children and Adults With Refractory Hematologic Malignancies

Joanne Kurtzberg, T J Ernst, Michael J. Keating et al. · Journal of Clinical Oncology · 2005 · 175 citations · Full text

Medicine, Pharmacokinetics, Pharmacology +17

A Phase I Study of the Pharmacokinetic and Safety Profiles of Oral Pazopanib With a High-Fat or Low-Fat Meal in Patients With Advanced Solid Tumors

Elisabeth I. Heath, E. Gabriela Chiorean, Christopher J. Sweeney et al. · Clinical Pharmacology & Therapeutics · 2010 · 100 citations

Pharmacy, Pharmacokinetics, Pharmacology +14

Phase I Dose-Finding Study of Pazopanib in Hepatocellular Carcinoma: Evaluation of Early Efficacy, Pharmacokinetics, and Pharmacodynamics

Thomas Yau, Pei‐Jer Chen, Pierre Chan et al. · Clinical Cancer Research · 2011 · 89 citations

Pharmacy, Oncology, Pharmacology +17